As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
The global cancer supportive care drugs market stood at a value of almost USD 22.57 billion in 2020. The market is expected to witness a steady growth during the forecast period of 2021-2026, growing at a CAGR of 1.2%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
It is estimated that the global cancer burden has risen to 18.1 million new cases and 9.6 million deaths in 2018. The most prominent kinds of cancer with the greatest demand for supportive care drugs are lung and breast cancer.
The global cancer supportive care drugs market can be broadly categorised on the basis of its drug class into:
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR report looks into the regional markets for cancer supportive care drugs like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
It is anticipated that increased biosimilar uptake, a large number of side effects connected with cancer treatment, increased expenditure on the healthcare sector, and the accessibility to the efficient therapeutic techniques, including target-specific and tailored treatments, are driving the global cancer supportive care drugs industry further. China and India are promising locations for the development of the cancer supportive care drugs industry. Factors such as increasing biosimilar uptake, effective healthcare reforms, and low-cost bases are providing a boost to the market in these two nations.
The report presents a detailed analysis of the following key players in the global cancer supportive care drugs market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.
|Scope of the Report||Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Class, Region|
|Breakup by Drug Class||G-CSFs, Erythropoietin Stimulating Agents (ESA), Antiemetics, Bisphosphonates, Opioids, NSAIDs, Others|
|Breakup by Region||North America, Europe, Asia Pacific, Latin America, Middle East and Africa|
|Market Dynamics||SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand|
|Competitive Landscape||Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications|
|Companies Covered||HELSINN Healthcare SA, F. Hoffmann-La Roche AG, ROG (SWX), Tesaro, Novartis International AG, NOVN (SWX), Heron Therapeutics, HRTX (NASDAQ), Merck & Co., Inc., MRK (NYSE), Amgen Inc., Others|
|Report Price and Purchase Option||Explore our purchase options that are best suited to your resources and industry needs.|
|Delivery Format||Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.|
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
.5 Key Industrial Trends
7 Industry Opportunities and Challenges
8 Global Cancer Supportive Care Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Cancer Supportive Care Drugs Historical Market (2016-2020)
8.3 Global Cancer Supportive Care Drugs Market Forecast (2021-2026)
8.4 Global Cancer Supportive Care Drugs Market by Drug Class
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2016-2020)
22.214.171.124 Forecast Trend (2021-2026)
8.4.2 Erythropoietin Stimulating Agents (ESA)
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2016-2020)
184.108.40.206 Forecast Trend (2021-2026)
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2016-2020)
22.214.171.124 Forecast Trend (2021-2026)
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2016-2020)
184.108.40.206 Forecast Trend (2021-2026)
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2016-2020)
22.214.171.124 Forecast Trend (2021-2026)
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2016-2020)
184.108.40.206 Forecast Trend (2021-2026)
8.5 Global Cancer Supportive Care Drugs Market by Region
8.5.1 Market Share
220.127.116.11 North America
18.104.22.168 Asia Pacific
22.214.171.124 Latin America
126.96.36.199 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
188.8.131.52 United States of America
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
184.108.40.206 United Kingdom
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
220.127.116.11 Saudi Arabia
18.104.22.168 United Arab Emirates
22.214.171.124 South Africa
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 HELSINN Healthcare SA
126.96.36.199 Company Overview
188.8.131.52 Product Portfolio
184.108.40.206 Demographic Reach and Achievements
12.2.2 F. Hoffmann-La Roche AG (SWX: ROG)
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
12.2.3 Merck & Co., Inc. (NYSE: MRK)
126.96.36.199 Company Overview
188.8.131.52 Product Portfolio
184.108.40.206 Demographic Reach and Achievements
12.2.4 Amgen Inc.
220.127.116.11 Company Overview
18.104.22.168 Product Portfolio
22.214.171.124 Demographic Reach and Achievements
12.2.5 Novartis International AG (SWX: NOVN)
126.96.36.199 Company Overview
188.8.131.52 Product Portfolio
184.108.40.206 Demographic Reach and Achievements
13 Industry Events and Developments
List of Figures and Tables
1. Global Cancer Supportive Care Drugs Market: Key Industry Highlights, 2016 and 2026
2. Global Cancer Supportive Care Drugs Historical Market: Breakup by Drug Class (USD Million), 2016-2020
3. Global Cancer Supportive Care Drugs Market Forecast: Breakup by Drug Class (USD Million), 2021-2026
4. Global Cancer Supportive Care Drugs Historical Market: Breakup by Region (USD Million), 2016-2020
5. Global Cancer Supportive Care Drugs Market Forecast: Breakup by Region (USD Million), 2021-2026
6. North America Cancer Supportive Care Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
7. North America Cancer Supportive Care Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
8. Europe Cancer Supportive Care Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
9. Europe Cancer Supportive Care Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
10. Asia Pacific Cancer Supportive Care Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
11. Asia Pacific Cancer Supportive Care Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
12. Latin America Cancer Supportive Care Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
13. Latin America Cancer Supportive Care Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
14. Middle East and Africa Cancer Supportive Care Drugs Historical Market: Breakup by Country (USD Million), 2016-2020
15. Middle East and Africa Cancer Supportive Care Drugs Market Forecast: Breakup by Country (USD Million), 2021-2026
16. Global Cancer Supportive Care Drugs Market Structure
EMR is one of the foremost business intelligence and market research firms with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.
Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:
Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.
We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.
Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.
We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.
As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.
EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.
Other Analyst Tools and Data Models
Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.
Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.
Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.
Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.
Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.